VENUSREM

Venus Remedies Share PriceVenus Remedies

₹166.2
-3.45 (-2.03%)
As on 23 March, 2023 | 13:08 BSE: 526953 NSE: VENUSREM

Venus Remedies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Venus Remedies

Start SIP

Venus Remedies Share Price

  • Over 1 Month 14.35%
  • Over 3 Month -6.71%
  • Over 6 Month -21.87%
  • Over 1 Year -44.14%

Venus Remedies Key Statistics

P/E Ratio 14.1
PEG Ratio -0.2
Market Cap Cr 222
Price to Book Ratio 0.5
EPS 36.6
Dividend 0
Relative Strength Index 58.77
Money Flow Index 35.02
MACD Signal -0.07
Average True Range 8.12

Venus Remedies Investment Rating

  • Master Rating:
  • Venus Remedies has an operating revenue of Rs. 541.80 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Venus Remedies Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 109125155128
Operating Expenses Qtr Cr 102110137121
Operating Profit Qtr Cr 715187
Depreciation Qtr Cr 7987
Interest Qtr Cr 0000
Tax Qtr Cr 1010
Net Profit Qtr Cr 38112

Venus Remedies Technicals

EMA & SMA

Current Price
₹166.2
-3.45 (-2.03%)
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • 161.33
  • 50 Day
  • 164.67
  • 100 Day
  • 175.98
  • 200 Day
  • 202.56
  • 20 Day
  • 163.05
  • 50 Day
  • 161.14
  • 100 Day
  • 176.78
  • 200 Day
  • 194.59

Venus Remedies Resistance and Support

PIVOT
₹168.25
Resistance
First Resistance 176.5
Second Resistance 183.35
Third Resistance 191.6
RSI 58.77
MFI 35.03
MACD Single Line -0.07
MACD 0.21
Support
First Resistance 161.4
Second Resistance 153.15
Third Resistance 146.31

Venus Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 82,401 4,612,808 55.98
Week 64,724 4,501,540 69.55
1 Month 72,288 3,590,543 49.67
6 Month 42,151 2,416,506 57.33

Venus Remedies Result Highlights

Venus Remedies Synopsis

NSE-Medical-Diversified

Venus Remedies L is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 575.18 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2022. Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705.
Market Cap 226
Sales 517
Shares in Float 0.78
No of funds 7
Yield
Book Value 0.5
U/D Vol ratio 1
LTDebt / Equity 9
Alpha -0.24
Beta 1

Venus Remedies

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 41.76%41.76%41.76%
Mutual Funds
Foreign Portfolio Investors 1.07%1.13%0.96%
Individual Investors 50.05%50.18%49.97%
Others 7.12%6.93%7.31%

Venus Remedies Management

Name Designation
Mr. Pawan Chaudhary Chairman & Managing Director
Dr.(Mrs.) Manu Chaudhary Joint Managing Director
Mr. Peeyush Jain Deputy Managing Director
Mr. Ashutosh Jain Executive Director
Mr. Navdeep Sud Independent Director
Dr. Gilbert Wenzel Non Executive Director
Dr. S K Chadha Independent Director
Mr. Pravindra Singh Chauhan Independent Director
Dr.(Mrs.) Savita Gupta Independent Director
Mr. Akshansh Chaudhary Executive Director

Venus Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Venus Remedies MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Venus Remedies FAQs

What is Share Price of Venus Remedies ?

Venus Remedies share price is ₹166 As on 23 March, 2023 | 12:54

What is the Market Cap of Venus Remedies ?

The Market Cap of Venus Remedies is ₹222.2 Cr As on 23 March, 2023 | 12:54

What is the P/E ratio of Venus Remedies ?

The P/E ratio of Venus Remedies is 14.1 As on 23 March, 2023 | 12:54

What is the PB ratio of Venus Remedies ?

The PB ratio of Venus Remedies is 0.5 As on 23 March, 2023 | 12:54

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number